Literature DB >> 3522917

An overview of the management of cystic fibrosis.

J M Littlewood.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3522917      PMCID: PMC1290129     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  45 in total

1.  Response of sweat electrolyte concentrations to 9 alpha--fluorohydrocortisone in patients with cystic fibrosis and their families.

Authors:  C C LOBECK; N R MCSHERRY
Journal:  J Pediatr       Date:  1963-03       Impact factor: 4.406

2.  Life tables for cystic fibrosis.

Authors:  M J Robinson; A P Norman
Journal:  Arch Dis Child       Date:  1975-12       Impact factor: 3.791

3.  Course of cystic fibrosis in 95 patients.

Authors:  R C Stern; T F Boat; C F Doershuk; A S Tucker; F P Primiano; L W Matthews
Journal:  J Pediatr       Date:  1976-09       Impact factor: 4.406

4.  Clinical significance of tissue penetration of antibiotics in the respiratory tract.

Authors:  H P Lambert
Journal:  Scand J Infect Dis Suppl       Date:  1978

5.  Fecal chymotrypsin: a reliable index of exocrine pancreatic function in children.

Authors:  A Bonin; C C Roy; R Lasalle; A Weber; C L Morin
Journal:  J Pediatr       Date:  1973-10       Impact factor: 4.406

6.  Treatment and prevention of pulmonary complications of cystic fibrosis in infancy and early childhood.

Authors:  M B Mearns
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

7.  Pancreozymin secretin test of exocrine pancreatic funtion in cystic fribrosis and the significance of the result for the pathogenesis of the disease.

Authors:  B Hadorn; P G Johansen; C M Anderson
Journal:  Can Med Assoc J       Date:  1968-02-24       Impact factor: 8.262

8.  Fecal fat and nitrogen in healthy children and in children with malabsorption or maldigestion.

Authors:  D H Shmerling; J C Forrer; A Prader
Journal:  Pediatrics       Date:  1970-11       Impact factor: 7.124

9.  Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis.

Authors:  W J Jusko; L L Mosovich; L M Gerbracht; M E Mattar; S J Yaffe
Journal:  Pediatrics       Date:  1975-12       Impact factor: 7.124

10.  Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis.

Authors:  N Hoiby; E W Flensborg; B Beck; B Friis; S V Jacobsen; L Jacobsen
Journal:  Scand J Respir Dis       Date:  1977-04
View more
  2 in total

Review 1.  Cystic fibrosis.

Authors:  T J David
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

2.  Liver involvement in cystic fibrosis.

Authors:  Catherine Brigman; Andrew Feranchak
Journal:  Curr Treat Options Gastroenterol       Date:  2006
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.